Latest Period
Q4 2025
Security Snapshot
PROCEPT BioRobotics Corp - Common Stock (PRCT) Institutional Ownership
CUSIP: 74276L105
13F Institutional Holders and Ownership History from Q3 2021 to Q1 2026
Institutions Reporting
258
Shares (Excl. Options)
56,112,992
Price
$31.46
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- PRCT on Nasdaq
- Shares outstanding
- 56,408,600
- Price per share
- $23.46
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 56,112,992
- Total reported value
- $1,765,255,262
- % of total 13F portfolios
- 0%
- Share change
- -477,714
- Value change
- -$35,576,679
- Number of holders
- 258
- Price from insider filings
- $23.46
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PRCT - PROCEPT BioRobotics Corp - Common Stock is tracked under CUSIP 74276L105.
- 258 institutions reported positions in Q4 2025.
- 5 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 258 to 188 between Q4 2025 and Q1 2026.
- Reported value moved from $1,765,255,262 to $851,243,153.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 258 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 74276L105?
CUSIP 74276L105 identifies PRCT - PROCEPT BioRobotics Corp - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74276L105:
Significant Owners of PROCEPT BioRobotics Corp - Common Stock (PRCT) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ALLIANCEBERNSTEIN L.P. | 6.1% | $122,052,091 | 3,419,784 | AllianceBernstein L.P. | 30 Sep 2025 | |||
| T. Rowe Price Investment Management, Inc. | 5.9% | $100,039,657 | 3,271,408 | T. Rowe Price Investment Management, Inc. | 31 Dec 2025 | |||
| BNP Paribas Asset Management Holding S.A. | 5.5% | $94,634,366 | 3,094,649 | BNP Paribas Asset Management Holding S.A. | 31 Dec 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $70,538,954 | 2,820,430 | Vanguard Capital Management | 31 Mar 2026 | |||
| FMR LLC | 2.9% | -68% | $45,888,947 | -$86,724,702 | 1,610,138 | -65% | FMR LLC | 27 Feb 2026 |
As of 31 Dec 2025, 258 institutional investors reported holding 56,112,992 shares of PROCEPT BioRobotics Corp - Common Stock (PRCT). This represents 99% of the company’s total 56,408,600 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of PROCEPT BioRobotics Corp - Common Stock (PRCT) together control 76% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 9.2% | 5,202,306 | -0.06% | 0% | $163,664,546 |
| FMR LLC | 8.2% | 4,653,111 | -42% | 0.01% | $146,386,864 |
| BlackRock, Inc. | 7.7% | 4,347,033 | +3% | 0% | $136,757,659 |
| ALLIANCEBERNSTEIN L.P. | 6% | 3,385,422 | -1% | 0.03% | $106,505,376 |
| T. Rowe Price Investment Management, Inc. | 5.8% | 3,271,408 | +59% | 0.06% | $102,919,000 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 5.5% | 3,094,649 | +183% | 0.11% | $97,357,000 |
| MACKENZIE FINANCIAL CORP | 2.8% | 1,573,405 | +8.2% | 0.06% | $49,511,860 |
| Artisan Partners Limited Partnership | 2.7% | 1,520,700 | +11% | 0.07% | $47,841,222 |
| STATE STREET CORP | 2.6% | 1,489,029 | +12% | 0% | $46,844,852 |
| Champlain Investment Partners, LLC | 2.6% | 1,441,034 | +0.22% | 0.46% | $45,334,930 |
| Prosight Management, LP | 2.4% | 1,380,000 | +1692% | 9% | $43,414,800 |
| ArrowMark Colorado Holdings LLC | 2.4% | 1,349,831 | +20% | 0.93% | $42,465,683 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 1,328,514 | +1.6% | 0% | $41,802,740 |
| Chicago Capital, LLC | 2.1% | 1,190,995 | -24% | 0.93% | $37,468,687 |
| UBS Group AG | 1.9% | 1,052,944 | +11% | 0.01% | $33,125,618 |
| BAILLIE GIFFORD & CO | 1.8% | 1,015,978 | +18% | 0.03% | $31,962,667 |
| MORGAN STANLEY | 1.5% | 843,491 | -0.02% | 0% | $26,536,254 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.3% | 705,740 | -19% | 0% | $22,204,000 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 1.2% | 699,971 | +2.2% | 0.03% | $22,021,088 |
| Rhenman & Partners Asset Management AB | 1.1% | 611,000 | +57% | 1.8% | $19,222,060 |
| NORTHERN TRUST CORP | 0.98% | 553,103 | +11% | 0% | $17,400,621 |
| GOLDMAN SACHS GROUP INC | 0.92% | 517,732 | +88% | 0% | $16,287,849 |
| Bellevue Group AG | 0.91% | 515,430 | +11% | 0.31% | $16,215,428 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.82% | 462,373 | +0.47% | 0% | $14,546,255 |
| BANK OF AMERICA CORP /DE/ | 0.76% | 431,205 | +6.7% | 0% | $13,565,709 |
Institutional Holders of PROCEPT BioRobotics Corp - Common Stock (PRCT) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 34,028,943 | $851,243,153 | +$61,089,763 | $25.01 | 188 |
| 2025 Q4 | 56,112,992 | $1,765,255,262 | -$35,576,679 | $31.46 | 258 |
| 2025 Q3 | 57,841,334 | $2,064,355,728 | +$58,548,802 | $35.69 | 240 |
| 2025 Q2 | 53,324,298 | $3,071,191,009 | +$166,390,640 | $57.60 | 268 |
| 2025 Q1 | 50,441,243 | $2,938,766,560 | -$31,409,190 | $58.26 | 277 |
| 2024 Q4 | 50,343,754 | $4,055,248,024 | +$360,452,580 | $80.52 | 279 |
| 2024 Q3 | 45,709,508 | $3,653,668,263 | +$135,461,273 | $80.12 | 247 |
| 2024 Q2 | 43,960,206 | $2,685,525,179 | -$132,419,664 | $61.09 | 199 |
| 2024 Q1 | 45,557,093 | $2,251,459,753 | +$4,603,354 | $49.42 | 161 |
| 2023 Q4 | 45,620,767 | $1,912,068,256 | +$51,914,421 | $41.91 | 144 |
| 2023 Q3 | 44,490,169 | $1,459,568,563 | +$274,904,884 | $32.81 | 126 |
| 2023 Q2 | 35,958,665 | $1,271,025,645 | +$114,407,722 | $35.35 | 117 |
| 2023 Q1 | 32,981,587 | $936,651,489 | -$8,052,530 | $28.40 | 111 |
| 2022 Q4 | 32,804,052 | $1,362,629,543 | -$35,665,010 | $41.54 | 112 |
| 2022 Q3 | 33,681,921 | $1,396,307,426 | -$142,581,938 | $41.46 | 100 |
| 2022 Q2 | 34,861,572 | $1,139,650,723 | +$126,543,346 | $32.69 | 92 |
| 2022 Q1 | 30,975,874 | $1,083,745,329 | +$68,880,476 | $34.99 | 58 |
| 2021 Q4 | 29,451,521 | $732,329,128 | +$46,766,132 | $25.01 | 60 |
| 2021 Q3 | 27,226,333 | $1,027,223,763 | +$988,368,763 | $38.15 | 57 |